No win. No fee.

menu

Diabetes Medication Lawsuits

The American Diabetes Association (ADA) reports that in 2015, just over 30 million Americans—9.4 percent of the population—had diabetes, with 1.5 million newly diagnosed every year.

If you or a loved one have suffered injuries such as heart failure, pancreatic cancer, amputations, or death while taking a diabetes medication, contact the experienced defective drug attorneys at Chaffin Luhana LLP.

Diabetes Drug Lawsuits

The disease was the seventh leading cause of death that year, according to death certificates. The ADA suggests that the true number of deaths may be higher because only about 35­–40 percent of deceased people with diabetes had diabetes listed on their death certificate.

Diabetes is a disease in which blood sugar (glucose) levels are too high.  Glucose is the body’s favorite fuel. It gets it from the foods and beverages you consume. 

A healthy person eats a sandwich, and the body responds by releasing insulin, a hormone that helps break that sandwich down into glucose. The cells then use that glucose for energy.

In a person with diabetes, this process doesn’t work like it should. Either the body doesn’t make enough insulin (type 1 diabetes), or it can’t efficiently use the insulin it does make (type 2 diabetes). Either way, the result is too much glucose in the blood. Without treatment, elevated blood glucose levels can cause possible complications, including:

  • Heart Disease
  • Stroke
  • Kidney Disease
  • Eye Problems
  • and Nerve Damage.

Diabetes medications are designed to help the body process that excess glucose and to control blood sugar levels so that patients can live normal, active lives.  Some, however, have been associated with serious and sometimes dangerous side effects that can put patients’ lives at risk.

This sort of outcome can be devastating for patients and their families who trust pharmaceutical companies to make sure their products are safe for their intended use. 

Chaffin Luhana offers dedicated legal representation for people who were harmed by certain diabetes drugs. If you or someone you love was injured due to taking a diabetes medication, we may be able to help you. To learn more, schedule a free, no-obligation consultation today.

Have You or a Loved One Been Seriously Injured by a Diabetes Medication?

Different Medications for Type-2 Diabetes

There are a variety of type-2 diabetes medications available to help patients keep blood sugar levels under control. Patients work with their doctors to determine which medication is right for them.

Unfortunately, several have been linked with potentially dangerous side effects. In many cases, the companies were aware of these side effects long before they warned doctors or patients about them.

Incretin Mimetics

The body produces “incretin hormones”, which are natural hormones produced in the small intestine in response to eating. When you have a meal, incretin stimulates the pancreas to release insulin, which in turn helps the body process the resulting glucose from the meal.

Type-2 diabetes patients have an insulin resistance. By increasing the production of insulin to prevent the blood glucose levels from getting too high, the body can help make up for that problem.

Incretin mimetics are a type of diabetes medications that “mimic” certain incretin hormones, prompting the pancreas to release more insulin.

Some of these medications also prevent the pancreas from producing too much “glucagon,” a form of incretin that causes the liver to release stored glucose into the bloodstream.

Popular incretin mimetics include:

The FDA released a drug safety communication in 2013 reporting that incretin mimetic drugs could potentially increase the risk of pancreatitis (inflamed pancreas) and could also cause pre-cancerous changes in the pancreas.

The FDA cited a study, which was unpublished at the time, that found that the use of exenatide (Byetta, Bydureon) or sitagliptin (Januvia, Janumet/Janumet XR, Juvisync) could double the risk of developing acute pancreatitis.

A 2013 study in the medical journal Diabetes found that patients using incretin-related drugs had a higher rate of pancreatitis and pancreatic cancer than patients using other medications.

In 2013, all federally filed incretin mimetic lawsuits claiming pancreatic cancer were combined into one court in the Southern District of California in the In re: Incretin Mimetics Products Liability Litigation MDL (“Incretin Mimetic MDL”). 

In November 2015, the MDL judge dismissed the cases on preemption grounds.  The plaintiffs’ appealed and, in December 2017, the Ninth Circuit Court of Appeals reversed the MDL court’s ruling reinstating hundreds of pancreatic cancer cases involving incretin mimetic drugs, which are now proceeding in the MDL.

Byetta

What is Byetta?

Byetta (exenatide) is a twice-daily injected medication that was approved by the FDA in 2005 for the treatment of type-2 diabetes. It helps control blood sugar levels by mimicking an incretin called “glucagon-like peptide 1,” thereby increasing insulin production. It was the first incretin-mimetic drug to hit the market. It was originally manufactured by Amylin Pharmaceuticals which was later purchased by Bristol-Myers Squibb in 2012. Eli-Lilly co-sold Byetta until 2011. Then in 2014, AstraZeneca acquired Bristol-Myers Squibb.

Byetta Cancer Lawyer

Risks & Injuries Associated With Byetta

Byetta has been linked to an increased risk of pancreatic cancer in some studies, as well as to pancreatitis (inflamed pancreas) and to a potentially increased risk of thyroid cancer.

Byetta Lawsuits

Many Byetta lawsuits have already been filed against manufacturer Bristol-Myers Squibb as part of the Incretin Mimetic MDL in U.S. District Court for the Southern District of California. If you’ve suffered injuries due to taking the diabetes medication Byetta, contact our experienced lawyers today.

Bydureon

What is Bydureon?

Bydureon (exenatide) is an extended-release version of Byetta approved by the FDA in 2012 as a once-weekly injection for the treatment of type-2 diabetes. It functions the same way as Byetta, but is a longer-acting drug. Like Byetta, it is manufactured by AstraZeneca.

Risks & Injuries Associated With Bydureon

Bydureon, like Byetta, has been linked to an increased risk of pancreatic cancer in some studies, as well as to pancreatitis (inflamed pancreas). The FDA has also required a black box warning on Bydureon labels based on concerns that it may increase risk of thyroid cancer.

Bydureon Lawsuits

Many Bydureon lawsuits have already been filed against manufacturer AstraZeneca. In 2015, AstraZeneca settled 84 Byetta and Bydureon lawsuits related to cancer claims for an undisclosed amount. Bydureon is also included in the Incretin Mimetic MDL in U.S. District Court for the Southern District of California.

If you’ve suffered injuries due to taking the diabetes medication Bydureon, contact our experienced lawyers today.

Victoza

What is Victoza?

Victoza (liraglutide) is an injected medication approved by the FDA in 2010 for the treatment of type-2 diabetes. It also helps control blood sugar levels by mimicking the incretin glucagon-like peptide 1, and is manufactured by Novo Nordisk.

Victoza Cancer Attorney

Risks & Injuries Associated With Victoza

Victoza has also been linked to an increased risk of pancreatic cancer in some studies, as well as to pancreatitis (inflamed pancreas). The FDA has also required a black box warning on Victoza labels based on concerns that it may increase risk of thyroid cancer.

Victoza Lawsuits

Many Victoza lawsuits have already been filed against Novo Nordisk. In 2013, all federally filed Victoza lawsuits claiming pancreatic cancer are also included in the Incretin Mimetic MDL in U.S. District Court for the Southern District of California.

If you’ve suffered injuries due to taking the diabetes medication Victoza, contact our experienced lawyers today.

DPP-4 Inhibitors

The following medications belong to a class called dipeptidyl peptidase-4 (DPP-4) inhibitors or “gliptins”. This class of drugs helps control blood sugar by blocking the action of DPP-4, which is an enzyme that, if left to do its job, deactivates incretins.

By preventing DPP-4 from doing their job, these medications allow more incretins to survive and stimulate the pancreas to release insulin. That, in turn, helps regulate blood glucose levels.

DPP-4 Inhibitors also help reduce the production of glucagon in the liver, slow down digestion, and decrease appetite. These drugs, like incretin mimetics, have been linked to an increased risk of pancreatitis and pancreatic cancer, as well as to thyroid cancer.

Popular DPP-4 inhibitors include:

In December 2017, the FDA reported that DPP-4 inhibitors may also be linked to rhabdomyolysis, a condition that causes rapid destruction of skeletal muscle and can lead to serious kidney failure. The FDA is currently evaluating the need for regulatory action.

This class of medications is usually prescribed to patients who don’t respond well to traditional type-2 diabetes drugs like metformin and sulphonylureas.

Januvia

What is Januvia?

Januvia (sitagliptin) is an oral medication that was approved by the FDA 2006 for the treatment of type-2 diabetes. It also helps control blood sugar levels by inhibiting the action of DPP-4, and is manufactured by Merck & Co.

Januvia Lawsuit Attorney

Risks & Injuries Associated With Januvia

Januvia has been linked to an increased risk of pancreatic cancer in some studies, as well as to pancreatitis (inflamed pancreas), thyroid cancer, and potentially to rhabdomyolysis. In 2016, researchers found that sitagliptin is significantly associated with a higher risk of pancreatic cancer, especially when the cumulative dose is < 33 700 mg. Researchers warned that the daily dose of the drug should be kept under 100 mg to reduce risk, and that those with kidney impairment should take less than 50 mg per day.

Januvia Lawsuits

Many Januvia lawsuits have already been filed against Merck & Co. In 2013, all federally filed Januvia lawsuits claiming pancreatic cancer were combined in the Incretin Mimetic MDL in U.S. District Court for the Southern District of California.

If you’ve suffered injuries due to taking the diabetes medication Januvia, contact our experienced lawyers today.

Janumet

What is Janumet?

Janumet (sitagliptin and metformin) is an oral medication that was approved by the FDA in 2007 for the treatment of type-2 diabetes. It contains sitagliptin, the active ingredient in Januvia, combined with metformin, which helps improve diabetics’ response to their own insulin, while lowering the amount of glucose created by the liver, and decreasing the amount absorbed by the intestines. Janumet is also manufactured by Merck & Co.

Janumet Lawyers

Risks & Injuries Associated With Janumet

Like Januvia, Janumet has also been linked to an increased risk of pancreatic cancer in some studies, as well as to pancreatitis (inflamed pancreas), thyroid cancer, and potentially to rhabdomyolysis.

Janumet Lawsuits

Many Janumet lawsuits have already been filed against Merck & Co. In 2013, all federally filed Janumet lawsuits claiming pancreatic cancer were combined in the Incretin Mimetic MDL in U.S. District Court for the Southern District of California.

If you’ve suffered injuries due to taking the diabetes medication Janumet, contact our experienced lawyers today.

Onglyza

What is Onglyza?

Onglyza (saxagliptin) is an oral medication that was approved by the FDA in 2009 for the treatment of type-2 diabetes. It is another DPP-4 inhibitor, which helps control blood sugar levels by increasing the availability of incretin to stimulate the pancreas to produce more insulin. It was originally manufactured by Bristol-Myers Squibb, which was then purchased by AstraZeneca. Read more about the potential dangers of Onglyza

Onglyza Cancer Attorneys

Risks & Injuries Associated With Onglyza

Like other DPP-4 Inhibitor drugs, Onglyza has been linked with a potentially increased risk for pancreatitis, pancreatic cancer, thyroid cancer, and potentially to rhabdomyolysis. Studies have also linked Onglyza to heart failure. The FDA reviewed the data on Onglyza and heart disease based on the findings of a clinical trial (the SAVOR study). And in April 2016, the FDA issued a Safety Announcement, advising that the manufacturer was required to add new warnings to the Onglyza labels about the potential risk of heart failure.

Onglyza Lawsuits

Many Onglyza lawsuits have already been filed against Bristol Myers Squibb and AstraZeneca concerning Onglyza heart failure. In February 2018, the U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all federally filed Onglyza lawsuits into one court in the U.S. District Court for the Eastern District of Kentucky.

If you’ve suffered injuries due to taking the diabetes medication Onglyza, contact our experienced lawyers today.

Kombiglyze XR

What is Kombiglyze XR?

Kombiglyze XR (saxagliptin and metformin) is an oral medication that was approved by the FDA in 2010 for the treatment of type-2 diabetes. It is another DPP-4 inhibitor, designed to help diabetes patients who haven’t responded to other medications. It was originally manufactured by Bristol-Myers Squibb, which was then purchased by AstraZeneca.

Kombiglyze XR Lawsuit

Risks & Injuries Associated With Kombiglyze XR

Like Onglyza, Kombiglyze XR has been linked to pancreatitis, pancreatic cancer, thyroid cancer, and potentially to rhabdomyolysis, as well as to heart failure.

Kombiglyze XR Lawsuits

Kombglyze XR lawsuits involving heart failure are included in the Onglyza MDL proceeding in the U.S. District Court for the Eastern District of Kentucky.

If you’ve suffered injuries due to taking the diabetes medication Kombiglyze XR, contact our experienced lawyers today.

Nesina

What is Nesina?

Nesina (alogliptin) is an oral medication that was approved by the FDA in 2013 for the treatment of type-2 diabetes. It is another DPP-4 inhibitor, and works the same way. It is manufactured by Takada Pharmaceuticals.

Nesina Pancreatic Cancer Lawyer

Risks & Injuries Associated With Nesina

Like other incretin-related diabetes drugs, Nesina is linked to an increased risk of pancreatitis, pancreatic cancer, pancreatitis, pancreatic cancer, thyroid cancer, and potentially to rhabdomyolysis. This drug was also included in the 2016 FDA Safety Announcement about the risk of heart failure. 

Nesina Lawsuits

Plaintiffs who have been injured by Nesina may be eligible to file a Nesina lawsuit. If you’ve suffered injuries due to taking the diabetes medication Nesina, contact our experienced lawyers today.

Kazano

What is Kazano?

Kazano (alogliptin and metformin) is an oral medication that was approved by the FDA in 2013 for the treatment of type-2 diabetes. It is another DPP-4 inhibitor combined with metformin. It is also manufactured by Takada Pharmaceuticals.

Kazano Cancer Lawyer

Risks & Injuries Associated With Kazano

Like other incretin-related diabetes drugs, Kazano is linked to an increased risk of pancreatitis, pancreatic cancer, thyroid cancer, and potentially to rhabdomyolysis. This drug was also included in the 2016 FDA Safety Announcement about the risk of heart failure. 

Kazano Lawsuits

Plaintiffs who have been injured by Kazano may be eligible to file a Kazano lawsuit. If you’ve suffered injuries due to taking the diabetes medication Kazano, contact our experienced lawyers today.

Oseni

What is Oseni?

Oseni (alogliptin and pioglitazone) is an oral medication that was approved by the FDA in 2013 for the treatment of type-2 diabetes. It is another DPP-4 inhibitor combined with pioglitazone (Actos). It is also manufactured by Takada Pharmaceuticals.

Oseni Lawsuit Attorneys

Risks & Injuries Associated With Oseni

Like other incretin-related diabetes drugs, Nesina is linked to an increased risk of pancreatitis, pancreatic cancer, thyroid cancer, and potentially to rhabdomyolysis. This drug was also included in the 2016 FDA Safety Announcement about the risk of heart failure. 

Oseni Lawsuits

Plaintiffs who have been injured by Oseni may be eligible to file an Oseni lawsuit. If you’ve suffered injuries due to taking the diabetes medication Oseni, contact our experienced lawyers today.

SGLT-2 Inhibitors

Sodium-glucose co-transporter 2 (SGLT2) inhibitors are another newer class of diabetes medications that are used to help bring blood sugar levels under control.

SGLT2 is a protein that helps the kidneys reabsorb glucose. SGLT2 inhibitors block that resorption, encouraging the kidneys to excrete excess glucose through urine to stabilize the blood sugar levels. These drugs also help to increase the body’s sensitivity to insulin, and to increase uptake of glucose by the muscle cells.

Popular SGLT-2 inhibitors include:

The FDA has issued multiple safety warnings for these drugs. In September 2015, for example, the FDA warned that two of them—Invokana and Invokamet—could increase risk of bone fractures. In some cases, the drugs could decrease bone mineral density, leaving patients more vulnerable to potential fractures. They required the manufacturer to add updated warnings to their product labels concerning this risk.

In 2015, the FDA warned that SGLT2 inhibitors could create too much acid in the blood, resulting in a condition called “diabetic ketoacidosis (DKA).” The condition typically occurs when there’s not enough insulin in the body to provide glucose energy, so the body burns fat for fuel, instead, producing “ketones” that raise acid levels.

Symptoms include:

  • Nausea
  • Vomiting
  • Abdominal Pain
  • Fatigue
  • Trouble Breathing

If this occurs, the patient requires immediate attention or the condition can become life threatening, leading to coma and, possibly, death.

The FDA required updated warnings on the product labels regarding these risks and also warned in that same communication that these drugs could increase risk of urinary tract infections.

In 2016, the FDA issued another communication stating it were strengthening warnings on product labels for these drugs because of their link to kidney injury.

Between 2013 and 2015, the FDA received reports of 101 cases of acute kidney injury, some requiring hospitalization and dialysis, with the use of these drugs, particularly Invokana, Invokamet, and Farxiga.

Finally, in 2017, the FDA issued yet another safety communication warning that Invokana and Invokamet could increase risk of leg and foot amputations. The manufacturers were required to add a new black box warning on the product labels to reflect this risk, which are saved for the most serious or life-threating risks.

Farxiga

What is Farxiga?

Farxiga (dapagliflozin) is an oral medication that was approved by the FDA in 2014 for the treatment of type-2 diabetes. It is a SGLT2 inhibitor manufactured by Bristol Myers Squibb, which was then purchased by AstraZeneca.

Farxiga Kidney & Ketoacidosis Lawyer

Risks & Injuries Associated With Farxiga

Farxiga may increase risk of diabetic ketoacidosis (DKA), acute kidney injury, and urinary tract infections.

Farxiga Lawsuits

In April 2017, the JPML consolidated all federally filed Farxiga lawsuits into one court in the U.S. District Court for the Southern District of New York. Most of the cases concern DKA.

If you’ve suffered injuries due to taking the diabetes medication Farxiga, contact our experienced lawyers today.

Jardiance

What is Jardiance?

Jardiance (empagliflozin) is an oral medication that was approved by the FDA in 2014 for the treatment of type-2 diabetes. It is a SGLT2 inhibitor manufactured by Boehringer Ingelheim.

Jardiance Lawyer

Risks & Injuries Associated With Jardiance

Jardiance may increase risk of diabetic ketoacidosis (DKA), acute kidney injury, and urinary tract infections.

Jardiance Lawsuits

Plaintiffs who have been injured by Jardiance may be eligible to file a Jardiance lawsuit. If you’ve suffered injuries due to taking the diabetes medication Jardiance, contact our experienced lawyers today.

Invokana

What is Invokana?

Invokana (canagliflozin) is an oral medication that was approved by the FDA in 2013 for the treatment of type-2 diabetes. It is a SGLT2 inhibitor manufactured by Janssen Pharmaceuticals and parent company Johnson & Johnson. Read more about the potential dangers of Invokana.

Invokana Amputation Lawyer

Risks & Injuries Associated With Invokana

Invokana may increase risk of diabetic ketoacidosis (DKA), acute kidney injury, urinary tract infections, bone fractures, and leg and foot amputations.

Invokana Lawsuits

In December 2016, the U.S. JPML consolidated all federally filed Invokana and Invokamet lawsuits in the U.S. District Court for the District of New Jersey.

If you’ve suffered injuries due to taking the diabetes medication Invokana, contact our experienced lawyers today.

Invokamet

What is Invokamet?

Invokamet (canagliflozin and metformin)) is an oral medication that was approved by the FDA in 2014 for the treatment of type-2 diabetes. It is a SGLT2 inhibitor combined with metformin and manufactured by Janssen Pharmaceuticals and parent company Johnson & Johnson.

Invokamet Amputation Lawsuit

Risks & Injuries Associated With Invokamet

Invokamet may increase risk of diabetic ketoacidosis (DKA), acute kidney injury, urinary tract infections, bone fractures, and leg and foot amputations.

Invokamet Lawsuits

In December 2016, the U.S. JPML consolidated all federally filed Invokana and Invokamet lawsuits in the U.S. District Court for the District of New Jersey.

If you’ve suffered injuries due to taking the diabetes medication Invokamet, contact our experienced lawyers today.

My Diabetes Medication Caused an Injury — What Do I Do?

Diabetes Medication Injury Treatment

1) Get Medical Treatment Immediately

If you experience any of the symptoms or conditions mentioned above, the first thing you should do is seek immediate medical attention. It’s important that you take care of your health, first.

After seeking appropriate treatment, gather all the medical records that you have concerning your use of your diabetes medication, including when you started it, and how long you took it. You may want to create a folder that contains all of the information, including paperwork from your medical appointments. You’ll need this information should you decide to pursue a diabetes medication lawsuit.

2) Contact a Diabetes Medication Lawyer

Next, contact an experienced personal injury lawyer with extensive knowledge of product liability concerning dangerous diabetes drugs. Your lawyer can go to work for you investigating all angles of your case, and gathering the evidence needed to support you in a diabetes medication lawsuit, allowing you time to recover and tend to your health.

Chaffin Luhana is currently accepting diabetes drug injury cases and has extensive experience fighting for patients’ rights. We can help you increase your odds of winning compensation in court.

Time to File is Limited

Do I Have a Case For My Diabetes Medication?

It can be very difficult to determine on your own if you may be eligible for a diabetes medication lawsuit or other similar lawsuit. There are many factors involved, including what drug you took and what injury you suffered, when you were diagnosed with the injury, and how serious the injury was.

You can gain some idea, though, by asking yourself the following questions:

  • Did you end up in the hospital because of your injury?
  • Did your doctor prescribe the drug you took to treat your type-2 diabetes?
  • Did you suffer from one of the injuries listed above while taking your diabetes medication, and was that injury linked with the drug you were taking?
  • Did you use the drug as directed in the product labeling?

If you answered “yes” to even one of these questions, you may be eligible to file a lawsuit  and should contact a diabetes medication attorney immediately.

Client Testimonial

"We called the number thinking nothing would happen but turned out to be the best move of our life. We are very grateful for the wonderful services of Chaffin Luhana LLP. [The attorneys and staff] made you feel very confident with the handing of the case – felt like they were long time friends and explained things so we could understand."
-Lawrence H.,
PRODUCT LIABILITY INJURY VICTIM

Speak With a Specialist

Learn how Chaffin Luhana can help you get the compensation you deserve.

What is My Diabetes Medication Lawsuit Worth?

Discovering about how much compensation you could expect for your injuries and other claims in a diabetes drug lawsuit would help you determine if the time and energy would be worth it. But that’s not an easy thing to determine on your own.

Play Video

Your diabetes medication attorney, however, can conduct a thorough investigation into your potential case, and after that, may be able to give you a better idea of where you stand. In addition to the facts surrounding the injury itself, there are your losses that need to be calculated, and these usually include your medical expenses, your lost wages, pain and suffering, and any future medical care you may need.

If you lost someone close to you because of a dangerous diabetes drug (loss of consortium), that can increase the complexity of your potential case. It takes time to get all the facts together, after which your diabetes drug attorney will be able to provide you with more information.

How Much Will My Diabetes Drug Lawsuit Cost?

As a plaintiff in a  diabetes medication lawsuit working with Chaffin Luhana, you will not owe any money up front. We work on contingency, which means that we don’t recover money unless you do. If you are awarded compensation in a settlement agreement or in an actual trial, your diabetes drug attorney will get a percentage of that award to pay for attorney’s costs.

When you go for your initial free consultation with a diabetes medication attorney, he or she will help explain the percentages so you can understand exactly how much of any legal award you may receive.

RECENT PRODUCT LIABILITY CASE RESULTS
$9 Million

INDIVIDUAL DEFECTIVE PRODUCT RECOVERY

$6.5 Million

INDIVIDUAL DEFECTIVE PRODUCT RECOVERY

$5 Million

INDIVIDUAL DEFECTIVE PRODUCT RECOVERY

Prior results do not guarantee or predict a similar outcome with respect to any future matter.

You Never Pay a Fee Unless We Win Your Case. Don't Wait. Contact Us Today.

File a Diabetes Drug Lawsuit

To find out if you qualify to file a Byetta, Januvia, Onglyza, Jardiance, Invokana, or other lawsuit for your diabetes medication, contact our experienced personal injury attorneys at Chaffin Luhana, LLP. We represent individuals nationwide who have suffered injuries due to defective drugs.

how not to be a lawyer

according to eric t. chaffin

“My father was a union witness at an arbitration in a steel mill outside of Pittsburgh. After the hearing, my father, dressed in blue jeans and a sweatshirt, stuck out his hand to shake hands with the company’s lawyer. The lawyer refused. The lawyer was not upset because my dad got the best of him but because he frowned upon working class people. I was the first person in my family to graduate from college. My dad used this story to remind me to respect others, to remember where I came from and as an example of how not to conduct myself as a lawyer.”

eric t. chaffin

request a free consulation

Fill out the form below or call us today at 888.316.2311 to receive a free consultation and let us help!
Close form